Literature DB >> 4113858

Structural studies on human Clq: non-covalent and covalent subunits.

K Yonemasu, R M Stroud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113858     DOI： 10.1016/0019-2791(72)90064-x

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  15 in total

1.  Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.

Authors:  R Hällgren
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

2.  Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.

Authors:  Hee Young Hwang; Marcus R Duvall; Stephen Tomlinson; Robert J Boackle
Journal:  Mol Immunol       Date:  2008-03-03       Impact factor: 4.407

3.  Subunit composition and structure of subcomponent C1q of the first component of human complement.

Authors:  K B Reid; R R Porter
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

4.  Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.

Authors:  K B Reid
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

5.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

6.  Isolation and characterization of two glycoproteins from patients with alveolar proteinosis.

Authors:  M A Passero; R W Tye; K H Kilburn; W S Lynn
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

7.  The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.

Authors:  P Faaber; P J Capel; R A Koene
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

8.  Amino acid sequence of the N-terminal 108 amino acid residues of the B chain of subcomponent C1q of the first component of human complement.

Authors:  K B Reid; E O Thompson
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

9.  Specific antisera to Clr. Quantitation of Clr in normal and pathological human sera.

Authors:  M M de Bracco; C L Christian; R M Stroud
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

10.  Hydroxylysine-linked glycosides of human complement subcomponent C1q and various collagens.

Authors:  H Shinkai; K Yonemasu
Journal:  Biochem J       Date:  1979-03-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.